Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 19Rectal Neoplasms 11Colorectal Neoplasms 11Colonic Neoplasms 11Central Nervous System Neoplasms 8Stomach Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 4Liver Neoplasms 4Kidney Neoplasms 4Carcinoma, Hepatocellular 4Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Ovarian Epithelial 3Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Recurrence 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neuroblastoma 2Lymphatic Metastasis 2Glioblastoma 2Breast Neoplasms, Male 2Astrocytoma 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1

Interventions

Temozolomide 1Radiotherapy 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Microarray Analysis 1Ifosfamide 1Doxorubicin 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hemangiopericytoma, Malignant × Chemotherapy, Adjuvant × Clear all
NCT00334854 2013-08-12

Ifosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
250 enrolled
Sarcoma

Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡